Literature DB >> 6423182

Fasting plasma magnesium concentrations and glucose disposal in diabetes.

C S Yajnik, R F Smith, T D Hockaday, N I Ward.   

Abstract

Fasting plasma concentrations of magnesium were measured by neutron activation analysis in 30 non-diabetics and 87 diabetics (55 non-insulin-treated, 32 insulin treated). Plasma concentrations of magnesium were lowest in the insulin treated group (mean 0.84 (SEM 0.01) mmol/1; 2.0 (0.02) mg/100 ml), intermediate in the non-diabetics (mean 0.89 (SEM 0.01) mmol/1; 2.2 (0.02) mg/100 ml), and highest in the non-insulin-treated diabetics (mean 0.95 (SEM 0.02) mmol/1; 2.3 (0.05) mg/100 ml). In all diabetics plasma magnesium concentrations were inversely related to plasma glucose values (rs = -0.33; p less than 0.01) and in non-insulin-treated patients to plasma insulin concentrations (rs = -0.28; p less than 0.05), the former confirming previous observations. In 67 of the diabetics the KG constant for disposal rate of glucose during a standard intravenous glucose tolerance test was directly related to fasting plasma magnesium concentrations, and this relation persisted after controlling for age, sex, body mass index, type of treatment, and glucose and insulin values. This direct relation of plasma magnesium concentration with glucose disposal was unexplained by its influence on insulin secretion but was related to insulin sensitivity; hence magnesium may be an important determinant of insulin sensitivity in maturity onset diabetes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6423182      PMCID: PMC1442636          DOI: 10.1136/bmj.288.6423.1032

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  19 in total

1.  [Critical study of the intravenous hyperglycemic triangle in normal man and determination of a "carbohydrate assimilation coefficient"].

Authors:  V CONARD; J R FRANCKSON; P A BASTENIE; J KESTENS; L KOVACS
Journal:  Arch Int Pharmacodyn Ther       Date:  1953-04

2.  Blood serum magnesium in portal cirrhosis and diabetes mellitus.

Authors:  F L STUTZMAN; D S AMATUZIO
Journal:  J Lab Clin Med       Date:  1953-02

3.  Metabolic changes in active chronic hepatitis.

Authors:  K G Alberti; C O Record; D H Williamson; R Wright
Journal:  Clin Sci       Date:  1972-05       Impact factor: 6.124

4.  Effect of magnesium on blood pressure.

Authors:  T Dyckner; P O Wester
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-11

5.  Insulin resistance and hypomagnesaemia: case report.

Authors:  K W Moles; J K McMullen
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-24

6.  Cardio-protective contribution of hard waters to magnesium in-take.

Authors:  J R Marier
Journal:  Rev Can Biol       Date:  1978-06

7.  Diurnal profiles of plasma magnesium and blood glucose in diabetes.

Authors:  H M Mather; G E Levin; J A Nisbet; L A Hadley; N W Oakley; T R Pilkington
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

8.  Hypomagnesemia, a risk factor in diabetic retinopathy.

Authors:  P McNair; C Christiansen; S Madsbad; E Lauritzen; O Faber; C Binder; I Transbøl
Journal:  Diabetes       Date:  1978-11       Impact factor: 9.461

9.  Hypomagnesaemia in diabetes.

Authors:  H M Mather; J A Nisbet; G H Burton; G J Poston; J M Bland; P A Bailey; T R Pilkington
Journal:  Clin Chim Acta       Date:  1979-07-16       Impact factor: 3.786

10.  Renal hypomagnesaemia in human diabetes mellitus: its relation to glucose homeostasis.

Authors:  P McNair; M S Christensen; C Christiansen; S Madsbad; I Transbøl
Journal:  Eur J Clin Invest       Date:  1982-02       Impact factor: 4.686

View more
  28 in total

1.  Hypomagnesaemia and type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  H W de Valk
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

2.  Increased plasma magnesium concentrations 3 years after biliopancreatic diversion with duodenal switch.

Authors:  Jakob Hedberg; Arvo Haenni
Journal:  Obes Surg       Date:  2012-11       Impact factor: 4.129

3.  Trace elements in diabetes mellitus.

Authors:  Praveeena S; Sujatha Pasula; K Sameera
Journal:  J Clin Diagn Res       Date:  2013-09-10

4.  The association of hypomagnesaemia, high normal uricaemia and dyslipidaemia in the patients with diabetic retinopathy.

Authors:  Navin S; Krishnamurthy N; Ashakiran S; C D Dayanand
Journal:  J Clin Diagn Res       Date:  2013-09-10

Review 5.  Thiazide-induced hyperglycaemia: a role for calcium-activated potassium channels?

Authors:  P Pickkers; M Schachter; A D Hughes; M D Feher; P S Sever
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

6.  Isolated hypomagnesaemia presenting as focal seizures in diabetes mellitus.

Authors:  F Matthey; C M Gelder; F E Schon
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-29

7.  Impaired insulin-induced erythrocyte magnesium accumulation is correlated to impaired insulin-mediated glucose disposal in type 2 (non-insulin-dependent) diabetic patients.

Authors:  G Paolisso; S Sgambato; D Giugliano; R Torella; M Varricchio; A J Scheen; F D'Onofrio; P J Lefèbvre
Journal:  Diabetologia       Date:  1988-12       Impact factor: 10.122

8.  Effects of improved glycaemic control on calcium and magnesium homeostasis in type II diabetes.

Authors:  A M McBain; I R Brown; D G Menzies; I W Campbell
Journal:  J Clin Pathol       Date:  1988-09       Impact factor: 3.411

Review 9.  The use of selected nutrition supplements and complementary and alternative medicine in liver disease.

Authors:  A James Hanje; Brett Fortune; Ming Song; Daniell Hill; Craig McClain
Journal:  Nutr Clin Pract       Date:  2006-06       Impact factor: 3.080

10.  Magnesium levels in plasma, erythrocyte, and platelet in hypertensive and normotensive patients with type II diabetes mellitus.

Authors:  F Corica; R Ientile; A Allegra; G Romano; F Cangemi; A Di Benedetto; M Buemi; D Cucinotta; D Ceruso
Journal:  Biol Trace Elem Res       Date:  1996-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.